Clinical trialNCT06177067RecruitingPhase 1Interventional

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

SponsorSt. Jude Children's Research HospitalEnrollment24Acute Leukemia of Ambiguous LineageRefractory Acute Myeloid LeukemiaRelapsed Acute Myeloid Leukemia

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Hiroto Inaba, MD, PhD
St. Jude Children's Research Hospital
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Rady Children'S Hospital
San Diego, California, United States
Dennis Kuo, MD
Recruiting
Children'S Hospital Colorado
Aurora, Colorado, United States
Kelly Faulk, MD
Recruiting
Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
Himalee Sabnis, MD
Recruiting
Children'S Mercy Hospital of Kansas City
Kansas City, Missouri, United States
Keith August, MD
Recruiting
Memorial Sloan- Kettering Cancer Center
New York, New York, United States
Maria-Luisa Sulis, MD
Recruiting
Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Lauren Pommert, MD
Recruiting
Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Sarah Tasian, MD
Recruiting
St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
Hiroto Inaba, MD, PhD
Recruiting
Ut Southwestern/simmons Cancer Center
Dallas, Texas, United States
Kathleen Ludwig, MD
Recruiting
Cook Children'S Medical Center
Fort Worth, Texas, United States
Holly Pacenta, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Apr 2024
Primary completion: 31 Oct 2026
Completion: 30 Apr 2027
Last update posted: 4 May 2026
Registered enrollment: 24
Registry id: NCT06177067

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.